Literature DB >> 32439078

What Is Organized Screening and What Is Its Value?

Jason A Dominitz1, Theodore R Levin2.   

Abstract

Most screening in the United States occurs in an opportunistic fashion, although organized screening occurs in some integrated health care systems. Organized colorectal cancer (CRC) screening consists of an explicit screening policy, defined target population, implementation team, health care team for clinical care delivery, quality assurance infrastructure, and method for identifying cancer outcomes. Implementation of an organized screening program offers opportunities to systematically assess the success of the program and develop interventions to address identified gaps in an effort to optimize CRC outcomes. There is evidence of that organized screening is associated with improvements in screening participation and CRC mortality.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer screening; Colonoscopy; Colorectal neoplasms; Mass screening; Occult blood; Patient navigation

Mesh:

Year:  2020        PMID: 32439078     DOI: 10.1016/j.giec.2020.02.002

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  4 in total

1.  Barriers and Facilitators to Colorectal Cancer Screening.

Authors:  Jason A Dominitz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-11

Review 2.  Disparities in Recommendations for Colorectal Cancer Screening Among Average-Risk Individuals: An Ecobiosocial Approach.

Authors:  Sharifah Saffinas Syed Soffian; Azmawati Mohammed Nawi; Rozita Hod; Mohd Rizal Abdul Manaf; Huan-Keat Chan; Muhammad Radzi Abu Hassan
Journal:  Risk Manag Healthc Policy       Date:  2022-05-13

Review 3.  Current and future colorectal cancer screening strategies.

Authors:  Aasma Shaukat; Theodore R Levin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-03       Impact factor: 73.082

4.  Timely Colonoscopy After Positive Fecal Immunochemical Tests in the Veterans Health Administration: A Qualitative Assessment of Current Practice and Perceived Barriers.

Authors:  Ashley C Mog; Peter S Liang; Lucas M Donovan; George G Sayre; Aasma Shaukat; Folasade P May; Thomas J Glorioso; Michelle A Jorgenson; Gordon Blake Wood; Candice Mueller; Jason A Dominitz
Journal:  Clin Transl Gastroenterol       Date:  2022-02-01       Impact factor: 4.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.